Evolus, Inc. (EOLS) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-03-20

Evolus, Inc. (EOLS) — no SEC Form 4 insider filings recorded in the last 90 days. 3 Form 8-K material event filings were reported by EOLS in the last 90 days. InsiderAlpha tracks every EOLS SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Evolus, Inc. (EOLS)

SIC classification	Pharmaceutical Preparations (SIC 2834)
SEC CIK	0001570562

90-Day SEC Filing Activity

Form 8-K filings (90d)	3
Latest Form 4 filing	2026-03-20

Recent EOLS Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-03-20	MOATAZEDI DAVID	See Remarks	S — Open-market sale [10b5-1]	13.7K	$4.75	$65K	SEC
2026-03-20	Avelar Rui	See Remarks	S — Open-market sale [10b5-1]	3.1K	$4.75	$15K	SEC
2026-03-17	Avelar Rui	See Remarks	S — Open-market sale [10b5-1]	30.0K	$4.89	$147K	SEC
2026-03-17	MOATAZEDI DAVID	See Remarks	S — Open-market sale [10b5-1]	116.7K	$4.89	$571K	SEC
2026-03-16	Avelar Rui	See Remarks	M — Option exercise [10b5-1]	8.8K	$0.00	—	SEC
2026-03-16	MOATAZEDI DAVID	See Remarks	M — Option exercise [10b5-1]	67.5K	$0.00	—	SEC
2026-02-17	Avelar Rui	See Remarks	A — Grant or award	94.9K	$0.00	—	SEC
2026-02-17	GILL DAVID N	Director	A — Grant or award	45.6K	$0.00	—	SEC
2026-02-17	MOATAZEDI DAVID	See Remarks	A — Grant or award	313.2K	$0.00	—	SEC
2026-02-17	Parschauer Karah Herdman	Director	A — Grant or award	45.6K	$0.00	—	SEC
2026-02-17	Stewart Brady	Director	A — Grant or award	45.6K	$0.00	—	SEC
2026-02-17	Mitchell Tatjana	Chief Financial Officer	A — Grant or award	121.5K	$0.00	—	SEC
2026-02-17	White Albert G III	Director	A — Grant or award	45.6K	$0.00	—	SEC
2026-02-17	Malik Vikram	Director	A — Grant or award	45.6K	$0.00	—	SEC
2025-09-08	Mitchell Tatjana	Chief Financial Officer	A — Grant or award	104.6K	$0.00	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Evolus, Inc. (EOLS). Updated in real time as new filings are submitted to the SEC.

Recent EOLS Form 8-K Material Events

2026-07-08 — Item 1.01, 7.01, 9.01 [SEC]
2026-06-12 — Item 5.07 [SEC]
2026-05-04 — Item 2.02, 7.01, 9.01 [SEC]
2026-03-13 — Item 5.02 · Leadership · neutral [SEC]
Evolus Inc. reclassified director Vikram Malik from Class III to Class II on March 13, 2026, to restore balance to the company's classified board structure following the departure of director Simone Blank. Malik continues as Chairman of the Board and Compensation Committee member
2026-03-03 — Item 1.01, 2.02, 2.03, 9.01 · Financing · neutral [SEC]
Evolus entered into a Loan and Security Agreement with Eclipse Business Capital LLC on March 3, 2026, establishing a $30 million senior secured asset-based revolving credit facility maturing in 2029. The facility carries interest at SOFR plus 4.25% margin, includes a $10 million

Recent Insider Filings

2026-03-20 — Avelar Rui (See Remarks)
2026-03-20 — MOATAZEDI DAVID (See Remarks)
2026-03-19 — MOATAZEDI DAVID (See Remarks)
2026-03-19 — Avelar Rui (See Remarks)
2026-02-20 — Parschauer Karah Herdman (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in EOLS insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

EOLS Insider Trading — FAQ

What is the latest insider trade for EOLS?: Evolus, Inc. (EOLS) had 0 insider filings in the last 90 days, with the most recent on 2026-03-20. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying EOLS stock?: 0 insider purchases of EOLS were filed in the last 90 days.
How many insiders are selling EOLS stock?: 0 insider sales of EOLS were filed in the last 90 days.
Where can I see EOLS SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every EOLS SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live EOLS dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.